In utero fluoride exposure at normal U.S. municipal ranges was associated with increased neurobehavioral problems in young kids, a prospective cohort study of 229 mother-child pairs in Los Angeles suggested.

Delayed-release/extended-release methylphenidate improves emotional lability among children with attention-deficit/hyperactivity disorder (ADHD), according to new research published in the Journal of Attention Disorders.

A new treatment for ADHD and other cognitive issues uses a neuro feedback headband to increase blood flow and oxygen to the prefrontal cortex. Fifth grader Clinton Pierce details how Mendi has helped him.

After announcing it would start selling its assets earlier this year, along with laying off nearly half the company, the medical app developer Akili Interactive has found a willing buyer.

The US Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) for the treatment of attention-deficit/hyperactivity disorder (ADHD), drug manufacturer Tris Pharma announced in a statement. The drug is the first approved liquid nonstimulant ADHD medication. The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy…

Parents and other grownups are currently being diagnosed with the disorder at the same rate as children. Why now?

Adults in the United States are seeking assessment, diagnosis, and treatment for attention-deficit/hyperactivity disorder (ADHD) at unprecedented rates. Psych Congress Network sat down with Lenard A. Adler, MD, director of the Adult ADHD Program at NYU Langone Health, on site at the 2024 APA Annual Meeting to dive deep into the particular ways that ADHD…

A study of university students in Lebanon found that 35.7% of those suffering from gaming disorder also suffer from attention-deficit/hyperactivity disorder (ADHD). This percentage was 24% among those without gaming disorder. Interestingly, the association between ADHD and gaming disorder was stronger in females than in males. The research was published in the journal PLOS ONE.

Virtual gaming has redefined what constitutes “playtime” for many children and adolescents, but no consensus has yet been reached on how helpful or harmful that trend may be, especially for youth living with attention-deficit/hyperactivity disorder (ADHD). A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City, though,…

Cingulate Inc has announced alignment with the US Food and Drug Administration (FDA) on the requirements for filing a New Drug Application (NDA) for its lead candidate, CTx-1301 (dexmethylphenidate). This medication is intended for the treatment of attention-deficit /hyperactivity disorder (ADHD) in patients aged 6 years and older.1

Adolescents with unmedicated attention-deficit/hyperactivity disorder (ADHD) who meet sleep guidelines have a lower risk for overweight and obesity (OW/OB) than those with short sleep duration, according to study findings published in the Journal of Pediatric Psychology.

Students with disabilities face a gamut of challenges when it comes to accessing high-quality K-12 education, including a shortage of specialized teachers. The nation’s growing English-learner population faces outsized needs as their English-language proficiency scores remain lower than pre-COVID-19-pandemic averages, and immigrant English learners in particular require more trauma-informed instruction.